Table 4. Correlation of immune-cell markers density with overall (OS) and progression-free (PFS) survival (Mentel-Cox analysis).

	OS (months)	P	PFS (months)	P
CD3
low	36	0.02	25	0.04
high	62		48
CD8
low	35	0.01	24	0.01
high	48		48
CD57
low	26	0.02	25	0.04
high	48		48
Granzyme b
low	48	0.3	35	0.3
high	44		44
CD4
low	48	0.6	35	0.4
high	44		35
CD20
low	44	0.3	36	0.3
high	48		36
CD163
low	44	0.4	35	0.2
high	35		35
S100
low	44	0.4	24	0.1
high	48		42
PDL1
low	35	0.4	36	0.6
high	60		36
CTLA4-lymphocytes
negative	44	0.4	35	0.4
positive	44		35
CTLA4-tumor cells
low	48	0.05	42	0.05
high	32		19